Baxi Pty Ltd is a limited by shares, Australian proprietary company. This corporation was registered on 2000-04-06 and was issued with the 092355318 ACN. Its Australian Business Number is 35092355318. Since 2014-09-25, the company is headquartered in ACT, post code 2912. The previous headquarters were located in ACT 2912 (from 2014-07-04 to 2014-09-25), ACT 2914 (from 2012-06-27 to 2014-07-04), and NSW 2444 (from 2000-05-10 to 2012-06-27). Baxi Pty Ltd was registered for the GST on 2000-07-01, up until 2021-12-08. Baxi Pty Ltd has been using the Baxi Pty Limited trading name since 2000-05-10 (it needs to be noted that the Australian Business Register no longer collects or updates trading names). In total the company used 1 trading name. The above data comes from the ABN database which was updated on 2021-12-13.
Status | From | To |
---|---|---|
Cancelled | December 8, 2021 | current |
Active | April 6, 2000 | December 8, 2021 |
Name | From | To |
---|---|---|
Baxi Pty Ltd | February 28, 2001 | current |
Baxi Pty Ltd | May 10, 2000 | February 28, 2001 |
Name | From | To |
---|---|---|
Baxi Pty Limited | May 10, 2000 | current |
Location | From | To |
---|---|---|
ACT 2912 | September 25, 2014 | current |
ACT 2912 | July 4, 2014 | September 25, 2014 |
ACT 2914 | June 27, 2012 | July 4, 2014 |
NSW 2444 | May 10, 2000 | June 27, 2012 |
Status | From | To |
---|---|---|
Registered | July 1, 2000 | December 8, 2021 |
Advertisements
Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2024 (http://data.gov.au, http://acnc.gov.au/ and http://abr.business.gov.au/), ©Intellectual Property Government Open Data 2024, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. Aubiz.net will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.